Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative IMRT, Cisplatin, and Bevacizumab in Endometrial Cancer
NCT01005329Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2009
- Primary completion
- Jun 2012
- Countries
- 3
01
Overview
A Phase 2 trial of bevacizumab in endometrial cancer (EC), sponsored by National Cancer Institute. Started Nov 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT01005329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01005329.